{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:29:14Z","timestamp":1780536554446,"version":"3.54.1"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T00:00:00Z","timestamp":1339372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n                    <jats:title>What's known on the subject? and What does the study add?<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Erectile dysfunction (\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            ) is often associated with endothelial dysfunction. It is also recognized as a marker for underlying vascular disease. There are missed opportunities to address cardiovascular risk factors in these men.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Simvastatin administered for 6 months improves sexual health\u2010related quality of life in men aged \u226540 years with untreated\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            . It reduces the risk of future cardiovascular events via a reduction in serum cholesterol in men with\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            . A non\u2010significant trend towards improving erectile function suggests longer trials with a more potent statin may be required. There is high probability (&gt;80%) of simvastatin being cost\u2010effective in men with\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            . Enquiry about erectile function provides the opportunity to address cardiovascular risk factors.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To evaluate the effectiveness and cost\u2010effectiveness of simvastatin on erectile function and health\u2010related quality of life in men aged \u226540 years with erectile dysfunction (\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            is common in men aged \u226540 years and impacts upon their overall health\u2010related quality of life and that of their partners.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Men aged \u226540 years who were not receiving lipid lowering or anti\u2010hypertensive medication and not at high cardiovascular risk were recruited from 10 general practices in the East of\n                            <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>\n                            ngland.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            In total, 173 eligible men with untreated\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            were randomized to double\u2010blind treatment with 40\u2009mg of simvastatin or placebo once daily for 6 months. Data were collected at three points over 30 weeks.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The main outcome was erectile function (International Index of Erectile Function\u20105 score). Secondary outcomes included male\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            \u2010specific quality of life (\n                            <jats:styled-content style=\"fixed-case\">MED<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">QoL<\/jats:styled-content>\n                            ), quality\u2010adjusted life years (\n                            <jats:styled-content style=\"fixed-case\">QALYs<\/jats:styled-content>\n                            ) using the generic Euroqol measure (\n                            <jats:styled-content style=\"fixed-case\">EQ<\/jats:styled-content>\n                            \u20105D), endothelial function, cardiovascular risk, cholesterol and health service costs.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            There was no significant difference in erectile function between the simvastatin and placebo groups (mean change, 1.28 vs 0.07,\n                            <jats:italic>z<\/jats:italic>\n                            = 1.1,\n                            <jats:italic>p<\/jats:italic>\n                            = 0.27), although a significant improvement in\n                            <jats:styled-content style=\"fixed-case\">MED<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">QoL<\/jats:styled-content>\n                            was observed (5% vs 2%,\n                            <jats:italic>z<\/jats:italic>\n                            = 2.09,\n                            <jats:italic>p<\/jats:italic>\n                            = 0.04).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Both 10\u2010year cardiovascular risk and low\u2010density lipoprotein were reduced (cardiovascular risk,\n                            <jats:italic>z<\/jats:italic>\n                            = \u22123.67,\n                            <jats:italic>p<\/jats:italic>\n                            &lt; 0.001; low\u2010density lipoprotein,\n                            <jats:italic>z<\/jats:italic>\n                            = \u22125.46,\n                            <jats:italic>p<\/jats:italic>\n                            &lt; 0.001), with no consistent change in endothelial function.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The frequency of sexual encounters is correlated with improved erectile function.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The joint distribution of costs and\n                            <jats:styled-content style=\"fixed-case\">QALY<\/jats:styled-content>\n                            benefits indicates that the probability of simvastatin being cost\u2010effective for willingness\u2010to\u2010pay thresholds of \u00a320\u2009000 and \u00a330\u2009000 is 86% and 83%, respectively.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Identifying men with\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            provides an opportunity to modify future cardiovascular risk and to improve\n                            <jats:styled-content style=\"fixed-case\">MED<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">QoL<\/jats:styled-content>\n                            by treating them with 40\u2009mg of simvastatin.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The joint analysis of costs and\n                            <jats:styled-content style=\"fixed-case\">QALY<\/jats:styled-content>\n                            benefits suggests that there is high probability that simvastatin is a cost\u2010effective strategy in men with\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The findings could influence urological and primary care practice by including questions on\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            during routine consultations and relevant clinical protocols. This provides an opportunity to impart lifestyle advice.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11241.x","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T09:33:18Z","timestamp":1339407198000},"page":"324-333","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Can simvastatin improve erectile function and health\u2010related quality of life in men aged \u226540 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [\n                    <scp>ISRCTN<\/scp>\n                    66772971]"],"prefix":"10.1111","volume":"111","author":[{"given":"Daksha","family":"Trivedi","sequence":"first","affiliation":[{"name":"Centre for Research in Primary and Community Care University of Hertfordshire  Hatfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kirby","sequence":"additional","affiliation":[{"name":"Centre for Research in Primary and Community Care University of Hertfordshire  Hatfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Wellsted","sequence":"additional","affiliation":[{"name":"Centre for Lifespan and Chronic Illness Research University of Hertfordshire  Hatfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Health Sciences University of York  York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Hackett","sequence":"additional","affiliation":[{"name":"Good Hope Hospital  Sutton Coldfield Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"O'Connor","sequence":"additional","affiliation":[{"name":"Centre for Research in Primary and Community Care University of Hertfordshire  Hatfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"van Os","sequence":"additional","affiliation":[{"name":"Centre for Lifespan and Chronic Illness Research University of Hertfordshire  Hatfield"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1006\/pmed.2000.0643"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900622"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.537"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/15.6.519"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.23.2996"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1998.00050.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00304-X"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220130-00002"},{"key":"e_1_2_8_10_1","unstructured":"British Society for Sexual Medicine.Guidelines on the management of erectile dysfunction.2007. Available at:http:\/\/www.bssm.org.uk\/downloads\/BSSM_ED_Management_Guidelines_2007.pdf. Accessed 3 February 2012"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02211.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.11.041"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01271.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.20104_1.x"},{"key":"e_1_2_8_15_1","first-page":"19","article-title":"Prevalence of cardiovascular risk factors in erectile dysfunction","volume":"5","author":"Walczak MK","year":"2002","journal-title":"J Gend Specif Med"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc2901.094094"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000132368.10458.66"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)34871-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00307-5"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102490\u20102\u20106"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)02090-2"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00156.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2006.00221.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365590801950279"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10122.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900472"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00449919"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-0233-1"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000239206.64270.5f"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.440"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.02.042"},{"issue":"5","key":"e_1_2_8_33_1","first-page":"V1","article-title":"JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice","volume":"91","year":"2005","journal-title":"Heart"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.15.1660"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.719005"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1183"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11241.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11241.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:28:24Z","timestamp":1761737304000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11241.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,11]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11241.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11241.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,11]]},"assertion":[{"value":"2012-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}